8 04, 2020

Orbsen Therapeutics Launches Clinical Trial to Address Leading Cause of Death Among COVID-19 Patients

2020-04-10T17:40:14+00:00April 8th, 2020|

GALWAY, Ireland, April 8, 2020 /PRNewswire/ -- Orbsen Therapeutics, a biotechnology company focused on the development and commercialization of best-in-class stromal cell immunotherapies, announced the beginning of a phase 2a clinical trial for the treatment of COVID-19 patients with acute respiratory distress syndrome (ARDS). Nearly 90 percent of deaths caused by COVID-19 are the result of ARDS.

1 07, 2019

Minister opens new Business Innovation Centre for life sciences start-ups

2019-07-01T18:03:10+00:00July 1st, 2019|

The new development complements the University’s existing Business Innovation Centres which are home to 52 early-stage companies. The University’s focus with the new Business Innovation Centre – North at Dangan Business Park is in driving Life Sciences research and innovation to develop services and solutions that demonstrably improve outcomes for patients through solutions that save [...]